Researchers from the University of Waterloo have developed a new technology that can hold an entire course of antibiotics in ...

Antibiotics have served as the mainstay ... or Clindamycin 300 mg orally twice daily for 7 days Bacterial vaginosis (BV) is a condition characterized by a loss of the indigenous vaginal ...

Researchers have developed a new technology that can hold an entire course of antibiotics in one tiny dose and deliver on demand just the right amount of medication that a particular patient needs to ...

Researchers from the University of Waterloo have developed a new technology that can hold an entire course of antibiotics in ...

Imagine trying to settle into a new home while constantly being attacked. That's what the bacterium Pseudomonas aeruginosa ...

To address the global threat of antibiotic resistance, scientists are on the hunt for new ways to sneak past a bacterial cell ...

A new group of bacterial toxins that can kill harmful bacteria and fungi have been discovered which may help against ...

The Bozhi Tian (UChicago) and Gürol Süel (UC San Diego) labs have developed a cutting-edge bioelectronic device that taps ...

As strains of pathogens resistant to frontline antibiotics become more common worldwide, clinicians are more often turning to combination treatments that degrade this resistance as a first treatment ...

or Clindamycin 300 mg orally twice daily for 7 days Bacterial vaginosis (BV) is a condition characterized by a loss of the indigenous vaginal lactobacilli and massive anaerobic overgrowth of the ...